A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT06028230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Parallel-group Treatment, Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a parallel, Phase 2, 3-arm study to evaluate the efficacy, safety, PK, and biological effects of SAR444656 compared with placebo in adult participants with moderate to severe HS aged ≥18 to 70 years. Study details include: * Screening period: up to 4 weeks (30 days) * Treatment duration: up to 16 weeks * Follow-up period: up to 4 weeks * Total study duration: up to 24 weeks * Number of visits: 14
Study identification
- NCT ID
- NCT06028230
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2023 (Actual)
- Primary completion
- Oct 9, 2025 (Actual)
- Completion
- Nov 12, 2025 (Actual)
- Last update posted
- Dec 11, 2025
2023 – 2025
United States locations
- U.S. sites
- 21
- U.S. states
- 8
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clear Dermatology & Aesthetics Center- Site Number : 8400006 | Scottsdale | Arizona | 85255 | — |
| Cosmetic Dermatology of Orange County- Site Number : 8400024 | Anaheim | California | 92807 | — |
| First OC Dermatology - Fountain Valley- Site Number : 8400007 | Fountain Valley | California | 92708-3701 | — |
| Paradigm Clinical Research - San Diego - ClinEdge - PPDS- Site Number : 8400021 | San Diego | California | 92108 | — |
| Clinical Trials Management Services - Thousand Oaks- Site Number : 8400028 | Thousand Oaks | California | 91360 | — |
| Advanced Dermatology and Cosmetic Care- Site Number : 8400025 | Valencia | California | 91355 | — |
| Encore Medical Research of Boynton Beach- Site Number : 8400002 | Boynton Beach | Florida | 33436 | — |
| Moore Clinical Research - Brandon- Site Number : 8400001 | Brandon | Florida | 33511 | — |
| Encore Medical Research - 6600 Taft St- Site Number : 8400005 | Hollywood | Florida | 33024 | — |
| Sullivan Dermatology- Site Number : 8400003 | Miami | Florida | 33162 | — |
| ARA Professionals- Site Number : 8400023 | Miami | Florida | 33176-1032 | — |
| Encore Medical Research - Weston- Site Number : 8400010 | Weston | Florida | 33331 | — |
| Dermatology Specialists Research (DS Research) - Indiana- Site Number : 8400012 | Clarksville | Indiana | 47129 | — |
| Dawes Fretzin Clinical Research- Site Number : 8400011 | Indianapolis | Indiana | 46256 | — |
| Beth Israel Deaconess Medical Center - 110 Francis St- Site Number : 8400013 | Boston | Massachusetts | 02215-5563 | — |
| Wayne Health - Dearborn- Site Number : 8400004 | Dearborn | Michigan | 48124-4085 | — |
| Revive Research Institute-1575 W Big Beaver Rd- Site Number : 8400008 | Troy | Michigan | 48084-3536 | — |
| Vial Health - DermDox Dermatology- Site Number : 8400020 | Camp Hill | Pennsylvania | 17011 | — |
| Clinical Research Philadelphia,LLC- Site Number : 8400026 | Philadelphia | Pennsylvania | 19114-1025 | — |
| UPMC Montefiore- Site Number : 8400009 | Pittsburgh | Pennsylvania | 15213 | — |
| Dermatology Specialists of Spokane- Site Number : 8400015 | Spokane | Washington | 99202-1332 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06028230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06028230 live on ClinicalTrials.gov.